AXA

AVP, a venture capital firm investing in high-growth technology companies, announces it has
completed the first closing of the second vintage of its Early Stage Fund (AVP Early Stage II)
with $150 million (€130 million). The first Early Stage Fund, a $110 million vehicle raised 2015,
has now been successfully deployed. The launch of the second Fund confirms AVP’s ambition
and commitment to early stage venture investing.

The fundraise has generated strong interest from existing and new investors and confirms the
differentiation of AVP’s approach to venture investment: strong team with deep sector
expertise, global presence and ability to add value beyond capital, notably through business
development opportunities with the investors of the Fund.
Similar to AVP Early Stage I, AVP Early Stage II will focus on North America, Europe & Israel and
will aim to invest in outstanding technology businesses, pre and early revenue, in enterprise
SaaS, consumer platform and SME solutions, with particular focus on fintech and digital health.
AVP Early Stage II will write initial checks up to $6 million and will support entrepreneurs in
their ambition by providing them business development opportunities with AXA and any other
relevant corporations.

AVP confirms with this fundraise, its position as a unique platform for investments in
technology with $600 million of assets under management (AUM) through three pillars of
investment expertise: Early Stage Fund, Growth Stage Fund and Fund of Funds, allowing its
investors to choose the most appropriate solution for tech investing.
AVP’s ambition is to become a preferred partner for entrepreneurs looking to grow their
business in Europe, North America and Israel. Since 2015, AVP has supported more than 40
companies in the Early and Growth stages with a focus on the following verticals: digital health,
cyber-security, enterprise software, artificial intelligence, fintech/insurtech, most recently
including investments in early stage companies such as Hackajob, K4Connect, Futurae and
growth stage companies like Zenjob, Phenom People and Happytal.
Francois Robinet, AVP Managing Partner, said: “This fundraise was completed at a record speed
with existing and new investors. This is a strong vote of confidence for our team and strategy,
and a recognition of what has been achieved with our first Early Stage Fund. We plan to hold
Paris – London – New York – San Francisco – Hong Kong
a second closing with additional new investors. This fundraise strengthens AVP’s positioning as
a leading player for ambitious entrepreneurs across Europe and North America.”

ABOUT AVP
AXA Venture Partners (AVP) is a venture capital fund investing in high-growth, technologyenabled
companies. AVP has built a unique investment platform specialized in tech investments
with $600 million of assets under management through three pillars of investment expertise:
Early Stage Fund, Growth Stage Fund and Fund of Funds. To date, AVP has invested in 40 Early
and Growth equity deals and 6 Fund investments. AVP team operates globally backed by offices
in San Francisco, New York, London, Paris and Hong Kong. Beyond investments, AVP provides
access to business development opportunities helping portfolio companies to scale globally
and accelerate their growth.

ABOUT THE AXA GROUP
The AXA Group is a worldwide leader in insurance and asset management, with 160,000
employees serving 105 million clients in 62 countries. In 2017, IFRS revenues amounted to Euro
98.5 billion and IFRS underlying earnings to Euro 6.0 billion. AXA had Euro 1,439 billion in assets
under management as of December 31, 2017.

For further information, please contact:
Sébastien LOUBRY
Partner, Business Development
sebastien@axavp.com
06.15.31.61.68

Hits: 12

Categories: News

Tags:

About the Author